Wells Fargo analyst Mohit Bansal upgraded Amgen to Overweight from Equal Weight with a price target of $265, down from $275.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on AMGN:
- Cantor biopharma/biotech analysts to hold analyst/industry conference call
- AMGEN ANNOUNCES 2023 SECOND QUARTER DIVIDEND
- Amgen to present new Repatha combined data from Phase 3 FOURIER trials
- Horizon Therapeutics reports Q4 EPS $1.21, consensus $1.09
- Early notable gainers among liquid option names on February 17th